Evidence map›Paper›PMID 41714626›Full record

ArticleNature communications2026

Coronaviruses reprogram the tRNA epitranscriptome to favor viral protein expression.

Elena Muscolino, Mireia Puig-Torrents, Jaime Buigues Bisquert, Diogo Correa Mendonca, Marc Talló-Parra, Gemma Perez-Vilaro, Omar Caño-Prades, Gavin R Meehan, Karen Kerr, Vanessa Herder and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. tRNA modifications in viral replication.The Journal of biological chemistry · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Elena MuscolinoMolecular Virology group, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4519-9415
Mireia Puig-TorrentsMolecular Virology group, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.ORCID http://orcid.org/0009-0007-5879-704X
Jaime Buigues BisquertInstituto de Biología Integrativa de Sistemas (I2SysBio), Parc Cientific de la Universitat de València, Valencia, Spain.ORCID http://orcid.org/0000-0002-9016-4628
Diogo Correa MendoncaCVR-CRUSH, MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Garscube Campus, Glasgow, United Kingdom.ORCID http://orcid.org/0000-0003-2356-8750
Marc Talló-ParraMolecular Virology group, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Gemma Perez-VilaroMolecular Virology group, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Omar Caño-PradesMolecular Virology group, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Gavin R MeehanCVR-CRUSH, MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Garscube Campus, Glasgow, United Kingdom.
Karen KerrCVR-CRUSH, MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Garscube Campus, Glasgow, United Kingdom.
Vanessa HerderCVR-CRUSH, MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Garscube Campus, Glasgow, United Kingdom.ORCID http://orcid.org/0000-0003-4814-1382
Miguel ChillónDepartment of Biochemistry and Molecular Biology, Institut de Neurociènces (INc), Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-0840-2111
Alfredo CastelloMRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Garscube Campus, Glasgow, United Kingdom.ORCID http://orcid.org/0000-0002-1499-4662
Rafael SanjuanInstituto de Biología Integrativa de Sistemas (I2SysBio), Parc Cientific de la Universitat de València, Valencia, Spain.ORCID http://orcid.org/0000-0002-1844-545X
Arvind H PatelCVR-CRUSH, MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Garscube Campus, Glasgow, United Kingdom.ORCID http://orcid.org/0000-0003-4600-2047
Juana DíezMolecular Virology group, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain. juana.diez@upf.edu.ORCID http://orcid.org/0000-0002-9013-0751

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronaviruses genomes are enriched in suboptimal A- and U-ending codons, which are typically associated with reduced translation efficiency due to limited cognate tRNA availability. How coronavirus efficiently express their proteins despite this limitation remains unclear. By analyzing their codon usage, we identify four tRNA modifications-inosine (I), queuosine (Q), 5-methylcarboxymethyluridine/ 5-methylcarboxymethyl-2-thiouridine (mcm

Indexed as

Coronavirus OC43, HumanGene Expression Regulation, ViralRNA, TransferSARS-CoV-2Viral ProteinsAnimalsCodonCodon UsageCoronavirus InfectionsEpitranscriptomeHumansProtein BiosynthesisRNA MethylationCodonRNA, TransferViral Proteins

Identifiers

PMID41714626
PMCPMC13031925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.